Do drug-eluting stents really have a higher risk of stent thrombosis than bare-metal stents?

被引：0
|
作者：
Flores Rios, X. [1 ]
Barge Caballero, E. [1 ]
Campo Perez, R. [1 ]
Pinon Esteban, P. [1 ]
Aldama Lopez, G. [1 ]
Salgado Fernandez, J. [1 ]
Calvino Santos, R. [1 ]
Vazquez Rodriguez, J. M. [1 ]
Vazquez Gonzalez, N. [1 ]
Castro Beiras, A. [1 ]
机构：
[1] Hosp Juan Canalejo, La Coruna, Spain
来源：
EUROPEAN HEART JOURNAL | 2009年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：240 / 240
页数：1
相关论文
共 50 条
  • [1] Stent thrombosis with drug-eluting and bare-metal stents Reply
    Palmerini, Tullio
    Zoccai, Giuseppe Biondi
    Della Riva, Diego
    Stone, Gregg W.
    LANCET, 2012, 380 (9842): : 646 - 647
  • [2] Are drug-eluting stents safer than bare-metal stents?
    Jensen, Lisette Okkels
    Christiansen, Evald Hoj
    LANCET, 2019, 393 (10190): : 2472 - 2474
  • [3] Drug-Eluting Stents Versus Bare-Metal Stents for Treatment of Bare-Metal In-Stent Restenosis
    Singh, Inder M.
    Filby, Steven J.
    El Sakr, Fredy
    Gorodeski, Eiran Z.
    Lincoff, A. Michael
    Ellis, Stephen G.
    Shishehbor, Mehdi H.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2010, 76 (02) : 257 - 262
  • [4] Drug-eluting or bare-metal stents?
    Irene Fernández-Ruiz
    Nature Reviews Cardiology, 2016, 13 (11) : 631 - 631
  • [5] Drug-Eluting Balloons or Stents for Bare-Metal Stent Restenosis
    Wiebe, Jens
    Colleran, Roisin
    Kastrati, Adnan
    JACC-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (12) : 1256 - 1258
  • [6] Drug-Eluting Versus Bare-Metal Stents for Bare-Metal In-Stent Restenosis
    Singh, Inder M.
    Filbly, Steven J.
    El Sakr, Fredy
    Gorodeski, Eiran Z.
    Lincoff, A. Michael
    Ellis, Stephen G.
    Shishehbor, Mehdi H.
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (6A): : 145D - 145D
  • [7] The Risk of Stent Thrombosis in Patients With Acute Coronary Syndromes Treated With Bare-Metal and Drug-Eluting Stents
    Kukreja, Neville
    Onuma, Yoshinobu
    Garcia-Garcia, Hector M.
    Daemen, Joost
    van Domburg, Ron
    Serruys, Patrick W.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (06) : 534 - 541
  • [8] Outcome Differences With the Use of Drug-Eluting Stents for the Treatment of In-Stent Restenosis of Bare-Metal Stents Versus Drug-Eluting Stents
    Steinberg, Daniel H.
    Gaglia, Michael A., Jr.
    Slottow, Tina L. Pinto
    Roy, Probal
    Bonello, Laurent
    De Labriolle, Axel
    Lemesle, Gilles
    Torguson, Rebecca
    Kineshige, Kimberly
    Xue, Zhenyi
    Suddath, William O.
    Kent, Kenneth M.
    Satler, Lowell F.
    Pichard, Augusto D.
    Lindsay, Joseph
    Waksman, Ron
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (04): : 491 - 495
  • [9] Effect of Stent Thrombosis on the Risk-Benefit Balance of Drug-Eluting Stents and Bare Metal Stents
    Flores-Rios, Xacobe
    Abugattas-de Torres, Juan P.
    Campo-Perez, Rosa
    Pinon-Esteban, Pablo
    Aldama-Lopez, Guillermo
    Salgado-Fernandez, Jorge
    Calvino-Santos, Ramon
    Vazquez-Rodriguez, Jose M.
    Vazquez-Gonzalez, Nicolas
    Castro-Beiras, Alfonso
    REVISTA ESPANOLA DE CARDIOLOGIA, 2010, 63 (05): : 528 - 535
  • [10] Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy
    Kereiakes, Dean J.
    Yeh, Robert W.
    Massaro, Joseph M.
    Driscoll-Shempp, Priscilla
    Cutlip, Donald E.
    Steg, P. Gabriel
    Gershlick, Anthony H.
    Darius, Harald
    Meredith, Ian T.
    Ormiston, John
    Tanguay, Jean-Francois
    Windecker, Stephan
    Garratt, Kirk N.
    Kandzari, David E.
    Lee, David P.
    Simon, Daniel I.
    Iancu, Adrian Corneliu
    Trebacz, Jaroslaw
    Mauri, Laura
    JACC-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (12) : 1552 - 1562
12345